1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Pediatric Vaccines Market, by Technology
6.1. Introduction
6.2. Attenuated Live Viruses
6.3. Conjugates
6.4. Inactivated Viruses
6.5. Polysaccharides
6.6. Recombinant
6.7. Subunits
6.8. Toxoids

7. Pediatric Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Monovalent
7.3. Multivalent

8. Pediatric Vaccines Market, by End User
8.1. Introduction
8.2. Hospital
8.3. Pediatric Clinic
8.4. Research Organization

9. Pediatric Vaccines Market, by Indication
9.1. Introduction
9.2. Haemophilus Influenzae Type B
9.3. Hepatitis
9.4. Human papillomavirus (HPV)
9.5. Measles
9.6. Meningitis A
9.7. Mumps
9.8. Pneumococcal Diseases
9.9. Polio
9.10. Rotaviruses
9.11. Rubella
9.12. Tetanus
9.13. Yellow Fever

10. California Pediatric Vaccines Market

11. Florida Pediatric Vaccines Market

12. Illinois Pediatric Vaccines Market

13. New York Pediatric Vaccines Market

14. Ohio Pediatric Vaccines Market

15. Pennsylvania Pediatric Vaccines Market

16. Texas Pediatric Vaccines Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. AstraZeneca PLC
18.2. CSL Limited
18.3. Eli Lilly and Company
18.4. GlaxoSmithKline PLC
18.5. Merck Sharp & Dohme Corp.
18.6. Mitsubishi Chemical Corporation
18.7. Novartis AG
18.8. Pfizer Inc.
18.9. Sanofi S.A.
18.10. Serum Institute of India Pvt. Ltd.

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES PEDIATRIC VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES PEDIATRIC VACCINES MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 6. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2027 (%)
FIGURE 21. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2027
FIGURE 23. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 28. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2027
FIGURE 30. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, 2018-2027 (USD MILLION)
FIGURE 31. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2027 (%)
FIGURE 37. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2020 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2027
FIGURE 39. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, 2018-2027 (USD MILLION)
FIGURE 40. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 41. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 43. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), 2018-2027 (USD MILLION)
FIGURE 44. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 45. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, 2018-2027 (USD MILLION)
FIGURE 46. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 47. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, 2018-2027 (USD MILLION)
FIGURE 48. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 49. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, 2018-2027 (USD MILLION)
FIGURE 50. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 51. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, 2018-2027 (USD MILLION)
FIGURE 52. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 53. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLIO, 2018-2027 (USD MILLION)
FIGURE 54. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 55. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, 2018-2027 (USD MILLION)
FIGURE 56. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 57. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, 2018-2027 (USD MILLION)
FIGURE 58. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 59. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, 2018-2027 (USD MILLION)
FIGURE 60. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 61. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, 2018-2027 (USD MILLION)
FIGURE 62. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 63. UNITED STATES PEDIATRIC VACCINES MARKET: FPNV POSITIONING MATRIX
FIGURE 64. UNITED STATES PEDIATRIC VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES PEDIATRIC VACCINES MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES PEDIATRIC VACCINES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY STATE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY STATE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY STATE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY STATE, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY STATE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY STATE, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY STATE, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY STATE, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY STATE, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES PEDIATRIC VACCINES MARKET: SCORES
TABLE 32. UNITED STATES PEDIATRIC VACCINES MARKET: BUSINESS STRATEGY
TABLE 33. UNITED STATES PEDIATRIC VACCINES MARKET: PRODUCT SATISFACTION
TABLE 34. UNITED STATES PEDIATRIC VACCINES MARKET: RANKING
TABLE 35. UNITED STATES PEDIATRIC VACCINES MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 36. UNITED STATES PEDIATRIC VACCINES MARKET: MERGER & ACQUISITION
TABLE 37. UNITED STATES PEDIATRIC VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 38. UNITED STATES PEDIATRIC VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 39. UNITED STATES PEDIATRIC VACCINES MARKET: INVESTMENT & FUNDING
TABLE 40. UNITED STATES PEDIATRIC VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 41. UNITED STATES PEDIATRIC VACCINES MARKET: LICENSE & PRICING

Companies Mentioned

AstraZeneca PLC
CSL Limited
Eli Lilly and Company
GlaxoSmithKline PLC
Merck Sharp & Dohme Corp.
Mitsubishi Chemical Corporation
Novartis AG
Pfizer Inc.
Sanofi S.A.
Serum Institute of India Pvt. Ltd.